These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 7641177

  • 1. Interleukin 4 retards dissemination of a human B-cell lymphoma in severe combined immunodeficient mice.
    Schwarz MA, Tardelli L, Macosko HD, Sullivan LM, Narula SK, Fine JS.
    Cancer Res; 1995 Sep 01; 55(17):3692-6. PubMed ID: 7641177
    [Abstract] [Full Text] [Related]

  • 2. Activated peripheral blood mononuclear cells from patients receiving subcutaneous interleukin-2 following autologous stem cell transplantation prolong survival of SCID mice bearing human lymphoma.
    Katsanis E, Weisdorf DJ, Miller JS.
    Bone Marrow Transplant; 1998 Jul 01; 22(2):185-91. PubMed ID: 9707028
    [Abstract] [Full Text] [Related]

  • 3. Establishing SCID mouse models of B-cell non-Hodgkin's lymphoma.
    Yan JS, Chen XY, Li WP, Yang Y, Song ZL.
    Ai Zheng; 2009 Feb 01; 28(2):181-3. PubMed ID: 19550134
    [Abstract] [Full Text] [Related]

  • 4. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS, Weijer K, van den Berk PC, Muller EJ, Miranda N, Bakker AQ, Heemskerk MH, Hekman A, de Gast GC, Gerritsen WR.
    Br J Cancer; 1999 Sep 01; 81(1):43-53. PubMed ID: 10487611
    [Abstract] [Full Text] [Related]

  • 5. Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
    Bohlen H, Manzke O, Titzer S, Lorenzen J, Kube D, Engert A, Abken H, Wolf J, Diehl V, Tesch H.
    Cancer Res; 1997 May 01; 57(9):1704-9. PubMed ID: 9135012
    [Abstract] [Full Text] [Related]

  • 6. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector.
    Tanaka F, Abe M, Akiyoshi T, Nomura T, Sugimachi K, Kishimoto T, Suzuki T, Okada M.
    Cancer Res; 1997 Apr 01; 57(7):1335-43. PubMed ID: 9102222
    [Abstract] [Full Text] [Related]

  • 7. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.
    de Kroon JF, de Paus RA, Kluin-Nelemans HC, Kluin PM, van Bergen CA, Munro AJ, Hale G, Willemze R, Falkenburg JH.
    Exp Hematol; 1996 Jul 01; 24(8):919-26. PubMed ID: 8690051
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a novel malignant B cell line with t(14;18) and t(4;11) established from a patient with acute monoblastic leukemia.
    de Kroon JF, Kluin-Nelemans HC, Kluin PM, Schuuring E, van Bergen CA, Oving I, Wessels H, Willemze R, Falkenburg JH.
    Exp Hematol; 1997 Sep 01; 25(10):1062-8. PubMed ID: 9293903
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice.
    Iwanuma Y, Chen FA, Egilmez NK, Takita H, Bankert RB.
    Cancer Res; 1997 Jul 15; 57(14):2937-42. PubMed ID: 9230205
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice.
    Durandy A, Emilie D, Peuchmaur M, Forveille M, Clement C, Wijdenes J, Fischer A.
    J Immunol; 1994 Jun 01; 152(11):5361-7. PubMed ID: 8189054
    [Abstract] [Full Text] [Related]

  • 20. Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assay.
    Yoshida M, Rybak RJ, Choi Y, Greenberg SJ, Barcos M, Kawata A, Matsuno F, Tsai H, Seon BK.
    Cancer Res; 1997 Feb 15; 57(4):678-85. PubMed ID: 9044845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.